p300 modulates HIV-1 gp120-induced apoptosis in human proximal tubular cells: Associated with alteration of TGF-β and Smad signaling

Nephron - Experimental Nephrology

Volumn 102, Issue 1, 2006, Pages

  Kapasi, Aditi A ^a   Fan, Saijun ^a   Singhal, Pravin C ^a,b  

^a ALBERT EINSTEIN COLLEGE OF MEDICINE   (United States)

^b LONG ISLAND JEWISH MEDICAL CENTER   (United States)

Author keywords

AP 1; Apoptosis; gp120; HIV 1; p300; Smads; Transforming growth factor

Indexed keywords

ACTIVATING TRANSCRIPTION FACTOR 2; CYTOKINE ANTIBODY; GLYCOPROTEIN GP 120; HISTONE ACETYLTRANSFERASE PCAF; MUTANT PROTEIN; SMAD7 PROTEIN; STRESS ACTIVATED PROTEIN KINASE; TRANSCRIPTION FACTOR AP 1; TRANSFORMING GROWTH FACTOR ALPHA; TRANSFORMING GROWTH FACTOR BETA;

ADULT; APOPTOSIS; ARTICLE; BINDING SITE; CONTROLLED STUDY; GENETIC TRANSFECTION; HUMAN; HUMAN CELL; HUMAN IMMUNODEFICIENCY VIRUS 1; KIDNEY PROXIMAL TUBULE; KIDNEY TUBULE CELL; MALE; PRIORITY JOURNAL; PROTEIN EXPRESSION; PROTEIN PHOSPHORYLATION; SENSITIZATION; SIGNAL TRANSDUCTION;

ANTIBODIES; APOPTOSIS; BINDING SITES; CELL LINE; DRUG SYNERGISM; E1A-ASSOCIATED P300 PROTEIN; HIV ENVELOPE PROTEIN GP120; HUMANS; KIDNEY TUBULES, PROXIMAL; P300-CBP TRANSCRIPTION FACTORS; PHOSPHORYLATION; PROTEIN STRUCTURE, TERTIARY; SIGNAL TRANSDUCTION; SMAD PROTEINS; SMAD2 PROTEIN; SMAD7 PROTEIN; TRANSCRIPTION FACTOR AP-1; TRANSCRIPTION FACTOR TFIIB; TRANSFECTION; TRANSFORMING GROWTH FACTOR BETA;

EID: 32844458117     PISSN: 16602129     EISSN: None     Source Type: Journal    
DOI: 10.1159/000088404     Document Type: Article

References (50)

1. Rao TK, Fillipone EJ, Nicastri AD: Associated focal and segmental glomerulosclerosis in the acquired immunodeficiency syndrome. N Engl J Med 1984;310:669-673.
2. D'Agati V, Appel GB: HIV infection and the kidney. J Am Soc Nephrol 1997;8:138-152.
3. Conaldi PG, Biancone L, Bottelli A, Wade-Evans A, Racusen, LC, Boccellino M, Orlandi V, Serra C, Camussi G, Toniolo A: 1998. HIV-1 kills renal tubular epithelial cells in vitro by triggering an apoptotic pathway involving caspase activation and Fas upregulation. J Clin Invest 1984;102:2041-2049.
4. Kimmel PL, Ferreira-Centeno A, Farkas-Szaliasi T, Abraham AA, Garrett CT: Viral DNA in microdissected renal biopsies of HIV infected patients with nephrotic syndrome. Kidney Int 1993;43:1347-1352.
5. Ray PE, Liu XH, Henry D, Dye LIII, Xu L, Orenstein JM, Schuztbank TE: Infection of human primary renal epithelial cells with HIV-1 from children with HIV-associated nephropathy. Kidney Int 1998;53:1217-1229.
6. Winston JA, Bruggman LA, Ross MD, Jacobson J, Ross L, D'Agati VD, Klotman ME, Klotman PE: Nephropathy and establishment of a reservoir of HIV type 1 during primary infection. N Engl J Med 2001;344:1979-1984.
7. Marras D, Bruggeman LA, Gao F, Tanji N, Mansukhani MM, Cara A, Ross MD, Gusella GL, Benson G, D'Agati VD, Hahn BH, Klotman ME, Klotman PE: Replication and compartmentalization of HIV-1 in kidney epithelium of patients with HIV-associated nephropathy. Nat Med 2002;8:522-526.
8. Bruggeman LA, Ross MD, Tanji N, Cara A, Dikman S, Gordon RE, Burns GC, D'Agati VD, Winston JA, Klotman ME, Klotman PE: Renal epithelium is a previously unrecognized site of HIV-1 infection. J Am Soc Nephrol 2000;11:2079-2087.
9. Yamamoto T, Noble NA, Miller DE, Gold LI, Hishida A, Nagase M, Cohen AH, Border WA: Increased levels of TGF-β in HIV-associated nephropathy. Kidney Int 1999;55:579-592.
10. Shukla RR, Kumar A, Kimmel P: TGF-β increases the expression of HIV-1 gene in transfected human mesangial cells. Kidney Int 1993;44:1022-1029.
11. Massague J: TGF-β signal transduction. Annu Rev Biochem 1998;67:753-791.
12. Hoodless PA, Tsukazaki T, Nishimatsu A, Attisano L, Wrana JL, Thomsen GH: Dominant-negative Smad2 mutants inhibit Activin/Vg1 signaling and disrupt axis formation in xenopus. Dev Biol 1999;207:364-379.
13. Savage C, Das P, Finelli AL, Townsend SR, Sun CY, Baird SE, Padgett RW: Caenorhabditis elegans genes sma-2, sma-3, and sma-4 define a conserved family of TGF-β pathway components. Proc Natl Acad Sci USA 1996;93:790-794.
14. Zhang Y, Feng XH, Wu RY, Derynck R: Receptor-associated Mad homologues synergies as effectors of the TGF-β response. Nature 1996;383:168-172.
15. Gibellini D, Celeghini C, Panaya R, Secchiero P, Capitani S, La Placa M, Zauli G: The engagement of CD4 surface antigen in the HEL haemopoietic cell line upregulates the TGF-β1 promoter activity. Br J Haematol 1997;97:571-578.
16. Dennler S, Itoh S, Vivien D, ten Dijke P, Huet S, Gauthier JM: Direct binding of Smad3 and Smad4 to critical TGFβ-inducible elements in the promoter of human plasminogen activator inhibitor-type 1 gene. EMBO J 1998;17:3091-3100.
17. Yingling JM, Datto MB, Wong C, Frederick JP, Liberati NT, Wang XF: The tumor suppressor, Smad-4, is a TGF-beta inducible, DNA binding protein. Mol Cell Biol 1997;17:7019-7028.
18. Preston GA, Srinivasan D, Barrett JC: Apoptotic response to growth factor deprivation involves cooperative interactions between c-Fos and p300. Cell Death Differ 2000;7:215-226.
19. Eilers A, Whitfield J, Vekrellis K, Neame SJ, Shah B, Ham J: C-Jun and Bax: Regulators of programmed cell death in developing neurons. Biochem Soc Trans 1999;27:790-797.
20. Felzien LK, Woffendin C, Hottiger MO, Subbramanian RA, Cohen EA, Nabel GJ: HIV transcriptional activation by the accessory protein, VPR, is mediated by the p300 co-activator. Proc Natl Acad Sci USA 1998;95:5281-5286.
21. 133 Phosphorylation and activation of CREB transcription factor in both Jurkat lymphoblastoid T cells and primary peripheral blood mononuclear cells. J Immunol 1998;160:3891-3898.
22. Lavin MF, Goldstone SD: Prolonged expression of c-Jun and associated activity of the transcription factor AP-1, during apoptosis in a human leukemic cell line. Oncogene 1994;9:2305-2311.
23. Smeyne RJ, Vendrell M, Hayward M, Baker SJ, Miao GG, Schilling K, Robertson LM, Curran T, Morgan JI: Continuous c-fos expression precedes programmed cell death in vivo. Nature 1993;363:166-169.
24. Pincus SH, Messer KG, Nara PI, Blattner WA, Colclough G, Reitz M: Temporal analysis of the antibody response to HIV envelope protein in HIV infected laboratory workers. J Clin Invest 1994;93:2505-2513.
25. Singhal PC, Sharma P, Kapasi AA, Reddy K, Franki N, Gibbons N: Morphine enhances macrophage apoptosis. J Immunol 1998;160:1886-1893.
26. Kapasi AA, Fan S, Ding G, Singhal PC: Role of 14-3-3ε, c-Myc/Max, and Akt phosphorylation in HIV-1 gp120-induced mesangial cell proliferation. Am J Physiol 2001;280:F333-F342.
27. Vancurova I, Miskolci V, Davidson D: NF-κB activation in TNF-α stimulated neutrophils is mediated by protein kinase Cδ. J Biol Chem 2001;276:19746-19752.
28. Habeshaw JA, Dalgleish AG, Bountiff L, Newell AL, Wilks D, Walker IC, Manca F: AIDS pathogenesis: HIV envelop protein and its interaction with cell proteins. Immunol Today 1990;11:418-425.
29. Pinching AJ, Nye KE: Defective signal transduction: a common pathway for cellular dysfunction in HIV infection? Immunol Today 1990;11:256-259.
30. Sodroski J, Goh WC, Rosen C, Campbell K, Haseltine A: Role of HTLV- III/LAV envelope in syncyntium formation and cytopathicity. Nature (Lond) 1986;332:470-474.
31. Weiss RA: Human immunodeficiency virus receptors. Semin Virol 1992;3:79-84.
32. Capon DJ, Ward RH: The CD4-gp120 interactions and AIDS pathogenesis. Annu Rev Immunol 1991;9:649-678.
33. Singhal PC, Sharma P, Singhal M, Gibbons N, Kapasi A, Reddy K: HIV-1 gp160 protein modulates proximal tubular cell proliferation and matrix synthesis. Cell Physiol Biochem 1997;7:43-52.
34. Benkirane M, Chun RF, Xiao H, Ogryzko VV, Howard BH, Nakatani Y, Jeang KT: Activation of integrated provirus requires histone acetyl transferase: P300 and P/CAF are coactivators for HIV-1 Tat. J Biol Chem 1998;273:24898-24905.
35. Marzio G, Tyagi M, Gutierrez MI, Giacca M: HIV-1 tat transactivator recruits p300 and CREB-binding protein histone acetyltransferases to the viral promoter. Proc Natl Acad Sci USA 1998;95:13519-13524.
36. Ott M, Schnolzer M, Garnica J, Fischle W, Emiliani S, Rackwitz HR. Verdin E: Acetylation of the HIV-1 Tat protein by p300 is important for its transcriptional activity. Curr Biol 1999;9:1489-1492.
37. Hottiger MO, Nabel GJ: Interaction of human immunodeficiency virus type 1 Tat with the transcriptional coactivators p300 and CREB binding protein. J Virol 1998;72:8252-8256.
38. Massague J: The TGF-β family of growth and differentiation factors. Cell 1987;49:437-438.
39. Sporn MB, Roberts AB, Wakefield LM, Assoian RK: TGF-β: Biological function and chemical structure. Science 1986;233:532-544.
40. Singhal PC, Sharma P, Loona R, Gibbons N, Franki N, Klotman PE: Enhanced proliferation, apoptosis and matrix accumulation by mesangial cells derived from HIV-1 transgenic mice. J Invest Med 1998;46:297-302.
41. Janknecht R, Wells NJ, Hunter T: TGF-β-stimulated cooperation of Smad proteins with the coactivators CBP/p300. Genes Dev 1998;12:2114-2119.
42. Shen X, Hu PP, Liberati NT, Datto MB, Frederick JP, Wang XF: TGF-β-induced phosphorylation of Smad3 regulates its interaction with co-activator p300/CREB-binding protein. Mol Biol Cell 1998;9:3309-3319.
43. Ghosh AK, Yuan W, Mori Y, Varga J: Smad-dependent stimulation of type I collagen gene expression in human skin fibroblasts by TGF-β involves functional cooperation with p300/CBP transcriptional coactivators. Oncogene 2000;19:3546-3555.
44. Kohlmeier L, Mendez M: TβRI phosphorylation of Smad2 on Ser465 and Ser467 is required for Smad2-Smad4 complex formation and signaling. J Biol Chem 1997;272:27678-27685.
45. Liberati NT, Datto MB, Frederick JP, Shen X, Wong C, Rougier-Chapman EM, Wang X-F: Smads bind directly to the Jun family of AP-1 transcription factors. Proc Natl Acad Sci USA 1999;96:4844-4849.
46. Nakao A, Afrakhte M, Moren A, Nakayama T, Christian JL, Heuchel R, Itoh S, Kawabata M, Heldin, NE, Heldin CH, ten Dijke P: Identification of Smad7, a TGFβ-inducible antagonist of TGF-β signaling. Nature 1997;389:631-635.
47. Ham J, Eilers A, Whitfield J, Neame SJ, Shah B: C-Jun and the transcriptional control of neuronal apoptosis. Biochem Pharmacol 2000;60:1015-1021.
48. Sanchez-Perez I, Perona R: Lack of c-Jun activity increases survival to cisplatin. FEBS Lett 1999;453:151-158.
49. Walton M, Woodgate AM, Sirimanne E, Gluckman P, Dragunow M: ATF-2 phosphorylation in apoptotic neuronal death. Brain Res Mol Brain Res 1998;63:198-204.
50. Sano Y, Harada J, Tashiro S, Gotoh-Mandeville R, Maekawa T, Ishii S: ATF-2 is a common nuclear target of Smad and TAK1 pathways in transforming growth factor-β signaling. J Biol Chem 1999;274:8949-8957.